AcquisitionOther
Aditxt, Inc. acquired Evofem Biosciences convertible securities
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Aditxt, Inc. -> Evofem Biosciences convertible securities · $13 million
Call option to purchase Evofem convertible securities as strategic investment.
Open source record (SEC) ↗